Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EBT Margin (2016 - 2020)

Historic EBT Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to 358.4%.

  • Avadel Pharmaceuticals' EBT Margin rose 3972700.0% to 358.4% in Q2 2020 from the same period last year, while for Mar 2021 it was 17.92%, marking a year-over-year increase of 1245200.0%. This contributed to the annual value of 82.52% for FY2020, which is 549200.0% up from last year.
  • According to the latest figures from Q2 2020, Avadel Pharmaceuticals' EBT Margin is 358.4%, which was up 3972700.0% from 84.74% recorded in Q1 2020.
  • Avadel Pharmaceuticals' 5-year EBT Margin high stood at 358.4% for Q2 2020, and its period low was 496.03% during Q4 2019.
  • Moreover, its 5-year median value for EBT Margin was 35.53% (2016), whereas its average is 41.46%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' EBT Margin plummeted by -110565400bps in 2016 and then surged by 3972700bps in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' EBT Margin stood at 41.96% in 2016, then crashed by -139bps to 16.36% in 2017, then plummeted by -2190bps to 374.72% in 2018, then plummeted by -32bps to 496.03% in 2019, then surged by 172bps to 358.4% in 2020.
  • Its EBT Margin stands at 358.4% for Q2 2020, versus 84.74% for Q1 2020 and 496.03% for Q4 2019.